While guidelines often only recommend screening for TB infection prior to TNF inhibitor therapy, these studies have shown that TNF inhibitors not only reactivate TB infection, but also increase susceptibility to new infections, stressing the importance of thorough surveillance of infection throughout treatment. Here, TNF is linked to infection.